Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2026-01-09 @ 1:45 AM
Study NCT ID:
NCT02584634
Status:
TERMINATED
Last Update Posted:
2023-07-07
First Post:
2015-10-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101)
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-13
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-21
First Submit QC Date:
None
Study First Post Date:
2015-10-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-01-13
Results First Submit QC Date:
None
Results First Post Date:
2022-02-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-21
Last Update Post Date:
2023-07-07
Last Update Post Date Type:
ACTUAL